AbbVie (ABBV) is expected to beat Q4 earnings estimates with strong performance from key products, including Skyrizi and Rinvoq.

The Board of Directors of Avery Dennison Corporation (NYSE:AVY) has declared a quarterly cash dividend of $0.88 per share. The dividend is payable on March 19, 2025 to shareholders of record on March ...

ABB Ltd. (ANN.L, ABB), a Swiss technology company, on Thursday reported higher profit, revenues and orders in its fourth quarter.

MicroStrategy stock is sitting below a closely watched level as bitcoin prices ease from highs. So, is it time to buy, sell ...

As Chinese startup DeepSeek rattles AI leaders, Nvidia stock puts focus on these rules for when to sell stocks.

AbbVie ABBV is set to report fourth-quarter and full-year 2024 earnings on Jan. 31, before the opening bell. The Zacks ...

James analyst Gary Nachman maintained an Outperform rating on AbbVie stock (NYSE:ABBV) with a $218.00 price target. The ...

Citi lowered the firm’s price target on AbbVie (ABBV) to $205 from $215 and keeps a Buy rating on the shares. Ahead of the Q4 earnings, the ...

AbbVie is one of the better pharmaceutical stocks on the scene, buttressed by a strong product lineup and a promising ...

AbbVie plans to release Q4 2024 results on Jan. 31. Analysts predict $14.8 billion in sales, $2.10 EPS. Immunology growth ...

The annualized dividend paid by AbbVie is $6.56/share, currently paid in quarterly installments, and its most recent dividend ...

Although AbbVie has lost patent exclusivity for its flagship drug, Humira, the company may soon be bigger and better.